DOYN
Pharmaceutical compound
From Wikipedia, the free encyclopedia
DOYN, also known as 4-ethynyl-2,5-dimethoxyamphetamine, is a serotonergic psychedelic of the phenethylamine, amphetamine, and DOx families.[1][2][3] According to Daniel Trachsel, it produces hallucinogenic effects with a dose range of 2 to 6 mg orally and a duration of 10 to 15 hours.[1] The drug's effects are described as typical psychedelic effects including fantasy, imagery, and visuals.[1] It is described as having a relatively short duration compared to 4-alkyl DOx derivatives like DOM, perhaps due to more rapid metabolism.[1] DOYN was first mentioned in the scientific literature by Trachsel in 2003 and was then described in more depth by him in 2013.[1][2][3] It is a controlled substance in Canada under phenethylamine blanket-ban language.[4]
- None
 | |
| Clinical data | |
|---|---|
| Other names | 4-Ethynyl-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-4-ethynylamphetamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 10–15 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C13H17NO2 |
| Molar mass | 219.284 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
